JPMorgan analyst Brian Cheng reiterated an Overweight rating and $48.00 price target on Tango Therapeutics Inc. (NASDAQ: TNGX).The analyst comments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Hot Comments